Investing.com investing.com 02 Jan, 2021 02:45 am

Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo By Reuters

Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo By Reuters
Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo

FILE PHOTO: Syringes to administer the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine are seen at a nursing home in Burgbernheim (Reuters) - Pfizer Inc (NYSE: PFE ) and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose of the vaccine by March 1, 2021, while staying within the study.The trial's Vaccine Transition Option allows all participants aged 16 or older the choice to discover whether they were given the placebo, "and for participants who learn they received the placebo, to have the option to receive the investigational vaccine while staying in the study," the companies said on their website https://www.Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them within the study, the companies said on the website.BioNTech founders warn of vaccine supply gaps -Spiegel p By Douglas Busvine BERLIN (Reuters) - BioNTech is working flat out with partner Pfizer (NYSE:PFE) to boost production of their COVID-19 vaccine, its founders said, warning.

Centers for Disease Control and Prevention and their local health authorities to offer the Vaccine Transition Option to participants in a prioritized manner," the companies said.Delta Air Lines CEO expects positive cash flow by spring p (Reuters) - Delta Air Lines (NYSE:DAL) CEO Ed Bastian said in a memo on Friday that he continues to expect that the company will achieve positive cash flow by the spring.

Read full story at investing.com